Akero Therapeutics and HistOindex present new analyzes of the Harmony study in phase 2b in oral and poster presentations on the EASL congress 2025

Your email address will not be published. Required fields are marked *

Name  *

Email  *

Website

Add Comment *

Save my name, email, and website in this browser for the next time I comment.

Post Comment